Carisma Therapeutics Inc (CARM)

$0.45 -0.10 (-17.89%)
Market Cap 18.87M
Revenue (ttm) 19.63M
Net Income (ttm) -60.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -308.10%
Debt to Equity Ratio 0.00
Volume 12,765,000
Avg Vol 16,942,572
Day's Range N/A - N/A
Shares Out 41.79M
Stochastic %K 26%
Beta 1.63
Analysts Sell
Price Target $2.42

Company Profile

Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidate includes CT-2401, which is in preclinical trail for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothel...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 491 6422
Address:
3675 Market Street, Suite 401, Philadelphia, United States
MoneyPennyStocks
MoneyPennyStocks Jun. 16 at 2:41 PM
$CARM still.nothing. listing approved maybe takes a few days, by Friday it's dead if it does not start moving up.
0 · Reply
BigShizzle54
BigShizzle54 Jun. 16 at 2:36 PM
$ONCO micro float, RS complete. LFG. $HCTI $ABP $CARM
1 · Reply
Mahmoud2139
Mahmoud2139 Jun. 16 at 2:27 PM
$CARM need any updates to go !!!
0 · Reply
StocksCC
StocksCC Jun. 16 at 2:25 PM
$CARM a little volume seems to move this thing immediately. Interesting..
0 · Reply
Bmsb7637
Bmsb7637 Jun. 16 at 2:08 PM
$CARM Check out this article from TipRanks | Carisma Therapeutics Secures Nasdaq Listing Approval | https://tipranks.onelink.me/WJho/t37r946d
0 · Reply
josephprince
josephprince Jun. 16 at 1:59 PM
$CARM this should not be under $1
0 · Reply
XXTraderXX
XXTraderXX Jun. 16 at 1:51 PM
$CARM seem like shorting algo disapear ( for now) 😅
1 · Reply
max315
max315 Jun. 16 at 1:47 PM
$CARM every morning it does the same thing. Keep playing it till it stops working. Wouldn't be surprised if it closes 30s and we'll do it again tomorrow.
0 · Reply
Sharnas1
Sharnas1 Jun. 16 at 1:44 PM
$CARM up samba up!
0 · Reply
FennickTradings
FennickTradings Jun. 16 at 1:44 PM
$CARM easy profit
0 · Reply
Latest News on CARM
Carisma Therapeutics Provides Corporate Updates

Mar 31, 2025, 4:30 PM EDT - 2 months ago

Carisma Therapeutics Provides Corporate Updates

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Feb 19, 2025, 7:30 AM EST - 4 months ago

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 5, 2025, 7:30 AM EST - 4 months ago

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline

Dec 9, 2024, 8:30 AM EST - 6 months ago

Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline

MRNA

Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Nov 27, 2024, 7:30 AM EST - 7 months ago

Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024

Nov 17, 2024, 7:30 AM EST - 7 months ago

Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

Nov 8, 2024, 7:30 AM EST - 7 months ago

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

MRNA

Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 7, 2024, 7:30 AM EST - 7 months ago

Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024

Nov 5, 2024, 9:05 AM EST - 7 months ago

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024

MRNA

Carisma Therapeutics Announces Changes to its Board of Directors

Oct 30, 2024, 4:30 PM EDT - 8 months ago

Carisma Therapeutics Announces Changes to its Board of Directors

Carisma Therapeutics Announces Upcoming Presentations at SITC 2024

Oct 4, 2024, 9:05 AM EDT - 9 months ago

Carisma Therapeutics Announces Upcoming Presentations at SITC 2024

Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases

Sep 10, 2024, 7:30 AM EDT - 9 months ago

Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases

MRNA

Carisma Therapeutics to Present at Upcoming Conferences

Sep 3, 2024, 7:30 AM EDT - 10 months ago

Carisma Therapeutics to Present at Upcoming Conferences

Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 8, 2024, 7:30 AM EDT - 11 months ago

Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Carisma Therapeutics Announces Upcoming Presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024

Aug 6, 2024, 7:30 AM EDT - 11 months ago

Carisma Therapeutics Announces Upcoming Presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024

Carisma Therapeutics Announces Expansion of Its Scientific Advisory Board

Aug 6, 2024, 7:30 AM EDT - 11 months ago

Carisma Therapeutics Announces Expansion of Its Scientific Advisory Board

Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna

Jun 27, 2024, 4:30 PM EDT - 1 year ago

Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna

Carisma Therapeutics Granted FDA Fast Track Designation for CT-0525 for the Treatment of HER2-overexpressing Solid Tumors

Jun 25, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics Granted FDA Fast Track Designation for CT-0525 for the Treatment of HER2-overexpressing Solid Tumors

Carisma Therapeutics to Participate in the Stifel 2024 Cell Therapy Forum

Jun 25, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics to Participate in the Stifel 2024 Cell Therapy Forum

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders

Jun 13, 2024, 4:30 PM EDT - 1 year ago

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders

Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference

May 30, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference

Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte

May 16, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte

Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 9, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024

May 8, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024

Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference

May 6, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference

Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer

May 2, 2024, 7:30 AM EDT - 1 year ago

Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer

Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Apr 22, 2024, 4:35 PM EDT - 1 year ago

Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Apr 1, 2024, 8:35 AM EDT - 1 year ago

Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting

Mar 21, 2024, 5:00 PM EDT - 1 year ago

Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting

Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference

Feb 28, 2024, 7:30 AM EST - 1 year ago

Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference

Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Dec 21, 2023, 7:00 AM EST - 1 year ago

Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration

Dec 14, 2023, 7:00 AM EST - 1 year ago

First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration

MRNA

Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte

Nov 28, 2023, 7:00 AM EST - 1 year ago

Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte

Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference

Nov 22, 2023, 7:30 AM EST - 1 year ago

Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference

Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Nov 9, 2023, 7:30 AM EST - 1 year ago

Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Carisma Presents Pre-Clinical Proof of Concept for in vivo CAR-M using mRNA platform in collaboration with Moderna at SITC

Oct 31, 2023, 9:25 AM EDT - 1 year ago

Carisma Presents Pre-Clinical Proof of Concept for in vivo CAR-M using mRNA platform in collaboration with Moderna at SITC

Carisma to Present First Results From in vivo CAR-M Collaboration with Moderna at SITC 2023

Oct 25, 2023, 9:11 AM EDT - 1 year ago

Carisma to Present First Results From in vivo CAR-M Collaboration with Moderna at SITC 2023

Carisma Therapeutics to Present at Upcoming Investor Conferences

Sep 5, 2023, 8:30 AM EDT - 1 year ago

Carisma Therapeutics to Present at Upcoming Investor Conferences

Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit

Sep 1, 2023, 8:30 AM EDT - 1 year ago

Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023

Aug 24, 2023, 8:30 AM EDT - 1 year ago

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023

Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Aug 10, 2023, 7:30 AM EDT - 2 years ago

Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Carisma Therapeutics Announces First Patient Dosed in Phase 1 Study of CT-0508 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HER2 Overexpressing Solid Tumors

Jun 28, 2023, 8:30 AM EDT - 2 years ago

Carisma Therapeutics Announces First Patient Dosed in Phase 1 Study of CT-0508 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HER2 Overexpressing Solid Tumors

Carisma Therapeutics to be Added to Russell 2000®, Russell 3000® and Russell Microcap® Indexes

Jun 26, 2023, 8:30 AM EDT - 2 years ago

Carisma Therapeutics to be Added to Russell 2000®, Russell 3000® and Russell Microcap® Indexes

Carisma Therapeutics Appoints Eric Siegel as General Counsel and Corporate Secretary and Terry Shields as Senior Vice President of Human Resources

Jun 14, 2023, 8:30 AM EDT - 2 years ago

Carisma Therapeutics Appoints Eric Siegel as General Counsel and Corporate Secretary and Terry Shields as Senior Vice President of Human Resources

Carisma Therapeutics to Present at Upcoming Investor Conferences in June 2023

Jun 5, 2023, 7:30 AM EDT - 2 years ago

Carisma Therapeutics to Present at Upcoming Investor Conferences in June 2023

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in June 2023

May 30, 2023, 4:30 PM EDT - 2 years ago

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in June 2023

Carisma Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights

May 11, 2023, 7:30 AM EDT - 2 years ago

Carisma Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights

Carisma Therapeutics to Present at the JMP Securities Life Sciences Conference

May 8, 2023, 4:30 PM EDT - 2 years ago

Carisma Therapeutics to Present at the JMP Securities Life Sciences Conference

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in May 2023

May 5, 2023, 4:30 PM EDT - 2 years ago

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in May 2023

Carisma Therapeutics to Present at The American Association for Cancer Research Annual Meeting

Apr 14, 2023, 12:51 PM EDT - 2 years ago

Carisma Therapeutics to Present at The American Association for Cancer Research Annual Meeting

MoneyPennyStocks
MoneyPennyStocks Jun. 16 at 2:41 PM
$CARM still.nothing. listing approved maybe takes a few days, by Friday it's dead if it does not start moving up.
0 · Reply
BigShizzle54
BigShizzle54 Jun. 16 at 2:36 PM
$ONCO micro float, RS complete. LFG. $HCTI $ABP $CARM
1 · Reply
Mahmoud2139
Mahmoud2139 Jun. 16 at 2:27 PM
$CARM need any updates to go !!!
0 · Reply
StocksCC
StocksCC Jun. 16 at 2:25 PM
$CARM a little volume seems to move this thing immediately. Interesting..
0 · Reply
Bmsb7637
Bmsb7637 Jun. 16 at 2:08 PM
$CARM Check out this article from TipRanks | Carisma Therapeutics Secures Nasdaq Listing Approval | https://tipranks.onelink.me/WJho/t37r946d
0 · Reply
josephprince
josephprince Jun. 16 at 1:59 PM
$CARM this should not be under $1
0 · Reply
XXTraderXX
XXTraderXX Jun. 16 at 1:51 PM
$CARM seem like shorting algo disapear ( for now) 😅
1 · Reply
max315
max315 Jun. 16 at 1:47 PM
$CARM every morning it does the same thing. Keep playing it till it stops working. Wouldn't be surprised if it closes 30s and we'll do it again tomorrow.
0 · Reply
Sharnas1
Sharnas1 Jun. 16 at 1:44 PM
$CARM up samba up!
0 · Reply
FennickTradings
FennickTradings Jun. 16 at 1:44 PM
$CARM easy profit
0 · Reply
josephprince
josephprince Jun. 16 at 1:41 PM
$CARM $1 today
0 · Reply
Frogs1111
Frogs1111 Jun. 16 at 1:41 PM
$CARM Gap filled..... No where to go but up up
0 · Reply
ggggggg18
ggggggg18 Jun. 16 at 1:38 PM
0 · Reply
ggggggg18
ggggggg18 Jun. 16 at 1:37 PM
$CARM If you wait for $0.3, it will come this week. You can leisurely buy more under $0.3 and hold on for up to 6 months. Fighting, let's escape the principal.
0 · Reply
FennickTradings
FennickTradings Jun. 16 at 1:37 PM
$CARM time for the push back to $1 land
1 · Reply
max315
max315 Jun. 16 at 1:36 PM
$CARM have a buy in at .36c
0 · Reply
FennickTradings
FennickTradings Jun. 16 at 1:35 PM
$CARM 😎🔥
0 · Reply
Spacerobot
Spacerobot Jun. 16 at 1:21 PM
$CARM I say this turns around. Short availability disappearing.
1 · Reply
aw20
aw20 Jun. 16 at 12:29 PM
$CARM back in at 0.42
1 · Reply
Sharnas1
Sharnas1 Jun. 16 at 11:42 AM
$CARM a little morale boost like sesn days
0 · Reply
StocksCC
StocksCC Jun. 16 at 8:26 AM
$CARM CTB rising https://fintel.io/ss/us/carm
0 · Reply
mkinvestinggroup
mkinvestinggroup Jun. 16 at 8:12 AM
$CARM https://ir.carismatx.com/ is their official IR site for some reason webull is having old non workable link just for info
0 · Reply